U.S. stock futures were moderately higher on Tuesday, a day after all major indices achieved all-time closing highs despite the latest mass shooting in Las Vegas.
Oil prices slipped with global benchmark Brent Crude down 0.20%, and U.S. crude West Texas Intermediate was down 0.24% recently as investors looked ahead to weekly data from the U.S. on stockpiles of crude and refined products due for release on Wednesday.
Data are expected to show motor vehicle sales of 16.7 million in September, compared to prior month’s sales of 16.1 million.
In equities, shares of Rigel Pharmaceuticals ( RIGL ) were 45.7% higher pre-bell after the company’s clinical trial of Fostamatinib met its primary endpoint.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.